RAS involvement in aneurysm development is largely based on several studies of different mouse models of arterial disease (including MFS mice) that have documented the therapeutic effects of inactivating the At1r gene or inhibiting the At1r receptor [11,12]. This evidence concerns the gene AGTR1 and aneurysm.